Moreover, the regulation of thyroid cancer cell proliferation and tumor growth can be achieved through the competition for miR-34a binding via the PI3K/AKT signaling pathway by downregulating miR-34a levels downstream of the hepatocyte growth factor receptor proteins by reducing lncRNA XIST expression (Liu et al., 2018). The gene discussed is MET; the disease is thyroid cancer.